A 7240 (see companion bill S 6542) – New York
Introduced: 2021 Status: Enacted
Directs the commissioner of health to review the rates of reimbursement made through the Medicaid program for ambulette transportation for rate adequacy and to report such findings to the legislature.
A 7245 (see companion bill S 4370) – New York
Introduced: 2021 Status: In Process
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, is to …
A 7268 (see companion bill S 3400) – New York
Introduced: 2023 Status: In Process
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
A 7296 – New York
Introduced: 2021 Status: In Process
Requires hospitals to inform emergency care patients whether the attending physician participates in the insured’s insurance policy; requires insurance companies to cover the cost of out-of-network care for patients who are unconscious or otherwise unable …
A 73 – New York
Introduced: 2019 Status: Inactive / Dead
Requires prescription information to be kept confidential.
A 7304 (see companion bill S 694) – New York
Introduced: 2017 Status: Inactive / Dead
Removes the requirement that federal participation must be provided for free-standing mental health clinics to be paid state funding owed to them for uncompensated care rendered
A 7346 (see companion bill S 926) – New York
Introduced: 2023 Status: In Process
Provides that the New York state health care quality and cost containment commission shall: evaluate each mandated benefit; investigate current practices of health plans with regard to the mandated benefit; investigate the potential premium impact …
A 741 – New York
Introduced: 2021 Status: In Process
Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of the ten prescription drugs on which the state expends the most money and which have had …
A 7465 (see companion bill S 4513) – New York
Introduced: 2023 Status: In Process
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be …
A 7474 – New York
Introduced: 2017 Status: Inactive / Dead
Authorizes ophthalmologists, optometrists and ophthalmic dispensers to establish limited liability companies.
A 7509 (see companion bill S 4788A) – New York
Introduced: 2018 Status: Enacted
INTERCHANGEABLE BIOLOGICAL PRODUCTS: Allows a pharmacist to dispense a lower cost generically equivalent drug product or interchangeable biological product.
A 7546 (see companion bill S 6956) – New York
Introduced: 2023 Status: In Process
Requires the commissioner of health to develop a sustainability plan for the state university of New York downstate medical center; provides that such sustainability plan shall not limit or alter the rights of employees pursuant …
A 755 – New York
Introduced: 2017 Status: Inactive / Dead
SUNY DOWNSTATE HOSPITAL: SUNY Downstate Hospital will operate up to four decentralized, freestanding primary and ambulatory care satellites in community based settings.
A 7554 (see companion bill S 7293) – New York
Introduced: 2023 Status: In Process
Relates to the performance standards that must be met by managed long term care plans; enables managed long term care plans operated by organizations that also operate an Institutional Special Needs Plan (ISNP) or a …
A 7585 (see companion bill S 6052) – New York
Introduced: 2017 Status: Inactive / Dead
Requires insurance and Medicaid coverage for inpatient and outpatient substance abuse treatment for a period of not less than forty-five days.
A 7598 (see companion bill S 6603) – New York
Introduced: 2021 Status: Inactive / Dead
Requires Medicaid managed care plans to reimburse retail pharmacies in an amount equal to the fee-for-service rate; allows retail pharmacies the opportunity to participate in another provider’s network under the medical assistance program; prohibits pharmacy …